Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
المصدر: NASDAQ US Markets / 14 نوفمبر 2024 07:43:11 America/New_York
Medications used to treat diabetes and obesity are the hottest commodities in healthcare right now. Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and Zepbound have all become blockbuster drugs, and their momentum doesn't seem to be going away.
https://www.nasdaq.com/articles/astrazeneca-buy-it-eyes-weight-loss-market